Does anyone have an informed views as to how the pharma companies are handling vaccine supply issues on the contractual side? Eg this situation - company x has signed contracts to supply 100 million doses but can only produce 50 million in the timeframe.
cc @Mikepeeljourno
Here are my assumptions:
- In this circumstance I would be very surprised if there were materially preferential contracts
- I would be even more surprised if the contracts didn’t include a great deal of provider flexibility
- I imagine the contracts or related documentation included an indicative supply schedule (I’d be amazed if the schedule was an obligation)
You can follow @Sime0nStylites.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:
Those who think consciousness raising & movement building are disconnected, or even a distraction from electoral politics have not paid attention to the history of social change.In this thread, we
Read more
The 2020s will be known as the Remote Work decadeA few predictions of what is likely to emerge[ a thread ] Third Space: Office and Working from Home will
Read more
1/29: Have you ever had a concept explained to you that helps frame complex issues you’ve been wrestling with and opens your eyes to new possibilities? A concept that I
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.